Activation of the immune coagulation system by murine hepatitis virus strain 3

Rev Infect Dis. 1989 May-Jun;11 Suppl 4(Suppl 4):S712-21. doi: 10.1093/clinids/11.supplement_4.s712.

Abstract

Viral infections result in alterations in hemostasis and coagulation. It has previously been shown that susceptibility to murine hepatitis virus strain 3 (MHV-3), a coronavirus, correlates directly with the spontaneous, T lymphocyte-instructed expression of a procoagulant monokine that exhibits prothrombin-cleaving activity (procoagulant activity [PCA]). A biologic role for PCA in the pathogenesis of MHV-3 infection is suggested by results of in vivo microscopic observations made during acute MHV-3 infection. Recently, it has been demonstrated that prostaglandin E2 abrogates the induction of PCA by MHV-3 both in vivo and in vitro and prevents hepatic necrosis and the associated microcirculatory changes. These data suggest that MHV-3 induces cellular injury through the activation of the coagulation cascade and provide further evidence for a role for PCA in the pathogenesis of MHV-3 infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Blood Coagulation Factors / biosynthesis
  • Blood Coagulation*
  • Hepatitis, Viral, Animal / blood*
  • Hepatitis, Viral, Animal / immunology
  • Humans
  • Liver / blood supply
  • Liver / pathology
  • Microcirculation
  • Murine hepatitis virus / immunology
  • Prostaglandins / metabolism

Substances

  • Blood Coagulation Factors
  • Prostaglandins
  • leukocyte procoagulant activity
  • macrophage procoagulant activity